Intramuscular 17α-hydroxyprogesterone caproate administration attenuates immunoresponsiveness of maternal peripheral blood mononuclear cells.

American journal of obstetrics and gynecology

Volumn 203, Issue 6, 2010, Pages

  Foglia, Lisa M ^a   Ippolito, Danielle L ^b   Stallings, Jonathan D ^b   Zelig, Craig M ^b   Napolitano, Peter G ^b  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

17-ALPHA-HYDROXY-PROGESTERONE CAPROATE; HYDROXYPROGESTERONE CAPROATE; INTERLEUKIN 6; PROGESTERONE DERIVATIVE;

ARTICLE; BLOOD; CELL CULTURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; MONONUCLEAR CELL; PREGNANCY; PREMATURITY; REFERENCE VALUE;

CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; HYDROXYPROGESTERONES; IMMUNOMODULATION; IMMUNOSUPPRESSION; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; PREGNANCY; PREMATURE BIRTH; REFERENCE VALUES;

EID: 79952116952     PISSN: None     EISSN: 10976868     Source Type: Journal    
DOI: None     Document Type: Article

References (0)